Navigation Links
Pharmaceutical Contract Manufacturing and API Sourcing in Central Europe and the Balkan States 2011
Date:8/16/2011

NEW YORK, Aug. 16, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical contract manufacturing and API sourcing in Central Europe and the Balkan states 2011

http://www.reportlinker.com/p0592261/Pharmaceutical-contract-manufacturing-and-API-sourcing-in-Central-Europe and-the-Balkan-states-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Legal_Services

Pharmaceutical contract manufacturing and API sourcing in Central Europe and the Balkan states 2011 is the latest report providing an in-depth analysis for pharmaceutical contract manufacturing and API sourcing in six Central European countries: the Czech Republic, Slovakia, Hungary, Poland, Romania and Bulgaria and three Balkan states: Croatia, Serbia and Slovenia. The report examines current and future trends in contract manufacturing in the whole of the region and describes key drivers and barriers for contract manufacturing in each country. 

With the growing market trends for pharmaceutical outsourcing, the region of Central Europe and the Balkans is becoming increasingly competitive to China and India. As a result many companies in the region offer attractive product and service offerings for contract manufacturing and API sourcing, based on their experience in the market, their specialized area of operations and developed product and service portfolio.  The report draws on comparisons with other regions, including the Far East and others. 

The report identifies the
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Calif. and BRUSSELS ... AMGN ) and UCB (Euronext Brussels: UCB) today ... evaluating effect of RomosozUmab Compared with Teriparatide in ... fracture pReviously treated with bisphosphonatE therapy). The study ... significant difference in favor of romosozumab in the ...
(Date:9/1/2015)... Sept. 1, 2015 Emerus Holdings, a ... emergent, inpatient and diagnostic care in partnership with ... a definitive agreement to receive a strategic investment ... a leading health care investment firm. ... patient-centric acute episodic and ambulatory clinical services to ...
(Date:9/1/2015)... IRVINE, Calif. , Sept. 1, 2015  Edwards ... in the science of heart valves and hemodynamic monitoring, ... Fargo Healthcare Conference at the Hyatt Regency Boston in ... 9, 2015. Michael A. Mussallem , ... keynote lunch speaker followed by a company discussion with ...
Breaking Medicine Technology:Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3
... /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: ... emerging leader in the development, assembly, marketing and sale ... that the Company,s growing business earned a BBB+ Credit Rating ... "Zhongguancun Association") and was approved as a member of ...
... SHANGHAI, Feb. 28, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... China-based pharmaceutical and biotechnology research and development outsourcing company, ... results for the fourth quarter and full year ended ... host a conference call to discuss the results at ...
Cached Medicine Technology:Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 2Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 3ShangPharma to Report Fourth Quarter and Full Year 2011 Financial Results on March 13, 2012 2
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and resolves ... treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful ...
(Date:9/1/2015)... (PRWEB) , ... September 01, ... ... Professional Background Screeners (NAPBS®) has announced that Edge Information Management has ... by the Background Screening Credentialing Council (BSCC). , ÔÇťAchieving and maintaining ...
(Date:9/1/2015)... ... September 01, 2015 , ... PetPace, the provider of ... signs and activity, today announced its integration with leading veterinary Practice Management Software ... veterinary hospital Practice Management Software packages in the US. Practice Management Software helps ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... government entities, announced today that it has hired Scott Sanderson, an experienced business ... this capacity, Sanderson will be responsible for establishing and managing new client relationships ...
(Date:9/1/2015)... ME (PRWEB) , ... September 01, 2015 , ... Royal ... large, new study that followed men and women for 19 years and found that, ... who did not take multivitamins. , The report is part of the September 2015 ...
Breaking Medicine News(10 mins):Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... AEGON N.V.,and the international humanitarian organization Right ... the organization,s mission to help,children in deprived areas ... donated EUR 1 million as part of a ... Winter Olympic games in Vancouver, Canada., (Photo: ...
... benefit from further study of vitespen, researchers say , , ... vitespen didn,t increase recurrence-free survival among kidney cancer patients ... standard treatment for kidney cancer, but many patients are ... effective adjuvant treatment, according to background information in the ...
... at work, one expert says , , THURSDAY, July 3 (HealthDay ... man,s chances of developing erectile dysfunction, Finnish researchers report. , ... body. It,s what we in vascular surgery refer to as ... Sadeghi-Nejad, an associate professor of urology at UMDNJ New Jersey ...
... director of the National Alliance on Mental Illness ... the lives,of individuals and families affected by mental ... monitor the callous treatment and tragic death of,Ms. ... the psychiatric,ward at Kings County Hospital in Brooklyn, ...
... Renowned stroke researcher Dr. Vladimir Hachinski has been named ... for his lifetime contributions in the field of neurology. ... University of Western Ontario in the Department of Clinical ... Dentistry. He is the founding and current chairman ...
... is a condition that unexpectedly and unexplainably takes the lives ... year. Now researchers of the European Molecular Biology Laboratory in ... crib or cot death, which remains the leading cause of ... The model, published in this week,s issue of Science ...
Cached Medicine News:Health News:AEGON and Right To Play Announce Global Partnership 2Health News:AEGON and Right To Play Announce Global Partnership 3Health News:Kidney Cancer Vaccine Shows No Boost in Survival 2Health News:Lots of Sex May Prevent Erectile Dysfunction 2Health News:Kings County Death: NAMI Calls for Criminal Probe; Survey Shows Psychiatric Emergency Room Delays Are National Problem 2Health News:Pioneering stroke researcher awarded Canada's highest honor 2Health News:New research sheds light on the molecular basis of crib death 2
Reptilase-Time from Bothrops atrox...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Pefakit TAFI Calibrators and Controls...
Plasma Control Level 2 - 1 ml...
Medicine Products: